Metformin Represses Self-Renewal of the Human Breast Carcinoma Stem Cells via Inhibition of Estrogen Receptor-Mediated OCT4 Expression
Published 2011 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Metformin Represses Self-Renewal of the Human Breast Carcinoma Stem Cells via Inhibition of Estrogen Receptor-Mediated OCT4 Expression
Authors
Keywords
Estrogens, Cancer stem cells, Breast cancer, Phenols, Stem cell therapy, Breast tumors, Cancer treatment, Tumor stem cells
Journal
PLoS One
Volume 6, Issue 11, Pages e28068
Publisher
Public Library of Science (PLoS)
Online
2011-11-24
DOI
10.1371/journal.pone.0028068
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Metformin Suppresses Ovarian Cancer Growth and Metastasis with Enhancement of Cisplatin Cytotoxicity In Vivo
- (2015) Ramandeep Rattan et al. NEOPLASIA
- Metformin and Incident Breast Cancer among Diabetic Women: A Population-Based Case-Control Study in Denmark
- (2011) J. L. F. Bosco et al. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION
- Metformin and the Incidence of Prostate Cancer in Patients with Type 2 Diabetes
- (2011) L. Azoulay et al. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION
- Metformin Decreases the Dose of Chemotherapy for Prolonging Tumor Remission in Mouse Xenografts Involving Multiple Cancer Cell Types
- (2011) D. Iliopoulos et al. CANCER RESEARCH
- Metformin inhibits breast cancer cell growth, colony formation and induces cell cycle arrest in vitro
- (2011) Irina N. Alimova et al. CELL CYCLE
- Metformin induces unique biological and molecular responses in triple negative breast cancer cells
- (2011) Bolin Liu et al. CELL CYCLE
- Metformin and Cancer Risk in Diabetic Patients: A Systematic Review and Meta-analysis
- (2010) A. DeCensi et al. Cancer Prevention Research
- Metformin and Other Biguanides in Oncology: Advancing the Research Agenda
- (2010) M. Pollak Cancer Prevention Research
- Metformin Suppresses Colorectal Aberrant Crypt Foci in a Short-term Clinical Trial
- (2010) K. Hosono et al. Cancer Prevention Research
- Metformin: A Therapeutic Opportunity in Breast Cancer
- (2010) A. M. Gonzalez-Angulo et al. CLINICAL CANCER RESEARCH
- Crosstalk between Insulin/Insulin-like Growth Factor-1 Receptors and G Protein-Coupled Receptor Signaling Systems: A Novel Target for the Antidiabetic Drug Metformin in Pancreatic Cancer
- (2010) E. Rozengurt et al. CLINICAL CANCER RESEARCH
- Breast cancer stromal fibroblasts promote the generation of CD44+CD24- cells through SDF-1/CXCR4 interaction
- (2010) Mingzhu Huang et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Stem Cells in Toxicology: Fundamental Biology and Practical Considerations
- (2010) K.-S. Kang et al. TOXICOLOGICAL SCIENCES
- Metformin use and prostate cancer in Caucasian men: results from a population-based case–control study
- (2009) Jonathan L. Wright et al. CANCER CAUSES & CONTROL
- Metformin Selectively Targets Cancer Stem Cells, and Acts Together with Chemotherapy to Block Tumor Growth and Prolong Remission
- (2009) H. A. Hirsch et al. CANCER RESEARCH
- New Users of Metformin Are at Low Risk of Incident Cancer: A cohort study among people with type 2 diabetes
- (2009) G. Libby et al. DIABETES CARE
- Antidiabetic Therapies Affect Risk of Pancreatic Cancer
- (2009) Donghui Li et al. GASTROENTEROLOGY
- Metformin and Pathologic Complete Responses to Neoadjuvant Chemotherapy in Diabetic Patients With Breast Cancer
- (2009) Sao Jiralerspong et al. JOURNAL OF CLINICAL ONCOLOGY
- Mysterious Metformin
- (2009) C. R. Chong et al. ONCOLOGIST
- Review Paper: Cancer Stem Cells and Cancer Nonstem Cells: From Adult Stem Cells or from Reprogramming of Differentiated Somatic Cells
- (2009) J. E. Trosko VETERINARY PATHOLOGY
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started